Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.99% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 4.89% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
iShares MSCI EAFE ETF
EFA
$79.9B
| $140M | 0.11% |
2,041,100
-2,168,000
| -52% | -$145M |
|
152
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $139M | 0.11% |
1,110,800
-362,500
| -25% | -$45.6M |
|
153
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$231M
| $138M | 0.11% |
736,250
-149,950
| -17% | -$25.2M |
|
154
Amphenol
APH
$206B
| $138M | 0.11% |
6,521,648
+4,962,164
| +318% | +$97.5M |
|
155
Alibaba
BABA
$306B
| $136M | 0.1% |
788,311
-1,545,322
| -66% | -$251M |
|
156
Norfolk Southern
NSC
$75.2B
| $136M | 0.1% |
1,029,528
+1,020,164
| +10,895% | +$124M |
|
157
Bristol-Myers Squibb
BMY
$130B
| $135M | 0.1% |
2,121,807
-119,553
| -5% | -$6.98M |
|
|
AGN
158
PUT
DELISTED
Allergan plc
AGN
| $135M | 0.1% |
658,500
+77,600
| +13% | +$18M |
|
|
LOGM
159
DELISTED
LogMein, Inc.
LOGM
| $135M | 0.1% |
1,223,321
+659,981
| +117% | +$74M |
|
160
Carter's
CRI
$1.46B
| $134M | 0.1% |
1,357,340
+343,144
| +34% | +$30.6M |
|
|
CELG
161
CALL
DELISTED
Celgene Corp
CELG
| $133M | 0.1% |
910,200
-73,100
| -7% | -$9.96M |
|
162
Honeywell
HON
$72.9B
| $132M | 0.1% |
1,029,393
-258,264
| -20% | -$32M |
|
163
Alcoa
AA
$14.3B
| $131M | 0.1% |
2,808,087
-698,874
| -20% | -$27.9M |
|
164
PUT
Wells Fargo
WFC
$264B
| $130M | 0.1% |
2,354,900
+411,200
| +21% | +$21.9M |
|
165
PUT
Gilead Sciences
GILD
$168B
| $129M | 0.1% |
1,590,000
+143,800
| +10% | +$11M |
|
166
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $128M | 0.1% |
287,200
-40,800
| -12% | -$19.4M |
|
|
AET
167
DELISTED
Aetna Inc
AET
| $127M | 0.1% |
801,638
-322,312
| -29% | -$50.3M |
|
168
PUT
Salesforce
CRM
$162B
| $127M | 0.1% |
1,362,200
+347,100
| +34% | +$31.9M |
|
169
PUT
ExxonMobil
XOM
$657B
| $127M | 0.1% |
1,552,200
-154,200
| -9% | -$12.2M |
|
170
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
| $127M | 0.1% |
3,705,400
-552,000
| -13% | -$18M |
|
171
Aptiv
APTV
$10.3B
| $127M | 0.1% |
1,289,195
+878,468
| +214% | +$82.9M |
|
172
WEX
WEX
$6.44B
| $126M | 0.1% |
1,124,837
+87,101
| +8% | +$9.44M |
|
173
Sherwin-Williams
SHW
$88.5B
| $126M | 0.1% |
1,055,763
+372,543
| +55% | +$42.7M |
|
|
SHPG
174
DELISTED
Shire pic
SHPG
| $126M | 0.1% |
822,380
+473,841
| +136% | +$74.3M |
|
175
Puma Biotechnology
PBYI
$453M
| $125M | 0.1% |
1,046,080
+108,283
| +12% | +$10.1M |
|
Similar funds
Ken Griffin's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.